Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases
- 1 September 2018
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 31 (9), 1457-1469
- https://doi.org/10.1038/s41379-018-0054-2
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- From Immunosuppression to Immunomodulation: Current Principles and Future StrategiesPathobiology, 2013
- Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general populationRheumatology, 2012
- Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studiesClinical Rheumatology, 2011
- Incidence and Risk Factors for Lymphoma in a Single-Center Inflammatory Bowel Disease PopulationDigestive Diseases and Sciences, 2010
- A transient benign lymph node-based proliferation of T-cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and CD11a antagonistsDiagnostic Pathology, 2008
- Lymphoma in rheumatoid arthritis: An immune system set up for failureArthritis & Rheumatism, 2006
- Risk of haematopoietic cancer in patients with inflammatory bowel diseaseGut, 2005
- Aggressive cutaneous T-cell lymphomas after TNFα blockadeJournal of the American Academy of Dermatology, 2004
- Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphomaArthritis & Rheumatism, 2003
- Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug AdministrationArthritis & Rheumatism, 2002